Description
COVID 19 EMERGENCY BNP REAGENTS
First action · last action
2020-07-31 · 2021-11-12
Transactions
2
First transaction's obligation
$1,298,747
Base + all options value (sum of deltas)
$294,653
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
GS07F161BA
NAICS
339113 · SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-07-31+$1,298,747= $1,298,747
- Mod P000012021-11-12-$1,004,094= $294,653
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-07-31 | +$1,298,747 | $1,298,747 | COVID 19 EMERGENCY BNP REAGENTS |
| Mod P00001· FUNDING ONLY ACTION | 2021-11-12 | −$1,004,094 | $294,653 | COVID 19 EMERGENCY BNP REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HE7NJQGP4ED6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0405 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $113,611 | FY2026 |
| 36C26226P1583 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $441,000 | FY2026 |
| 36C24226N0722 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $86,492 | FY2026 |
| 36C24226N0721 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $99,910 | FY2026 |
| 36C24226N0720 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $89,716 | FY2026 |
| 36C24426P0465 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $20,100 | FY2026 |
Other recipients under 6550 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0474 | ROCHE DIAGNOSTICS CORPORATION | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $21,384 | FY2026 |
| 36C25726N0497 | POLYMEDCO LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $30,770 | FY2026 |
| 36C25726N0477 | BECTON, DICKINSON AND COMPANY | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $337,374 | FY2026 |
| 36C25726D0094 | BECTON, DICKINSON AND COMPANY | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $0 | FY2026 |
| 36C25726N0476 | BECKMAN COULTER, INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,450,556 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25720F0354_3600_GS07F161BA_4732 · retrieved 2026-09-26.